North Shore Hospital is a large public hospital in Takapuna, New Zealand, serving the northern part of Auckland.

There are 663 beds in North Shore Hospital.

During the past decade, North Shore Hospital conducted 44 clinical trials. In the 10-year time frame, 44 clinical trials started and 28 clinical trials were completed, i.e. on average, 63.6% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 18 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North Shore Hospital" #1 sponsor was "Boston Scientific Corporation" with 9 trials, followed by "BeiGene" with 7 trials sponsored, "Hoffmann-La Roche" with 5 trials sponsored, "Elixir Medical Corporation" with 4 trials sponsored and "The George Institute" with 4 trials sponsored. Other sponsors include 45 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Shore Hospital" #1 collaborator was "National Health and Medical Research Council, Australia" with 5 trials as a collaborator, "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 2 trials as a collaborator, "Baxter Healthcare Corporation" with 2 trials as a collaborator, "Berry Consultants" with 2 trials as a collaborator and "Counties Manukau Health" with 2 trials as a collaborator. Other collaborators include 53 different institutions and companies that were collaborators in the rest 62 trials.

According to Clinical.Site data, the most researched conditions in "North Shore Hospital" are "Coronary Artery Disease" (14 trials), "Ulcerative Colitis" (3 trials), "Atherosclerosis" (2 trials), "B-cell Malignancies" (2 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "North Shore Hospital" in a lesser frequency.

Most popular intervention types in "North Shore Hospital" are "Drug" (48 trials), "Device" (18 trials), "Procedure" (10 trials), "Other" (8 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Zanubrutinib" (6 trials), "Etrolizumab" (4 trials), "Apremilast 20mg" (2 trials) and "Apremilast 30mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "North Shore Hospital" are 78 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are 28 active trials in "North Shore Hospital". 1 are not yet recruiting, 12 are recruiting, 13 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 43 completed trials in North Shore Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in North Shore Hospital, 4 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 20 trials that are defined as “Not Applicable".